Clinical Trials Logo

Signs and Symptoms, Digestive clinical trials

View clinical trials related to Signs and Symptoms, Digestive.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06248177 Recruiting - Microbiota Clinical Trials

Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).

FLORABIOTIC
Start date: January 16, 2024
Phase: N/A
Study type: Interventional

The goal of this randomized clinical trial is to evaluate the effect on the microbiota and the reduction in the number and/or intensity of symptoms of gastrointestinal discomfort of consuming a probiotic or placebo for 6 weeks in adult women and men. The main questions to answer are: 1. To study changes in the alpha diversity of the microbiota. 2. To evaluate changes in the salivary cortisol. For this purpose, a randomized, double blind crossover study has been designed. Target sample size is 30 subjects. Participants will be allocated in two groups for 16 weeks (6 weeks consuming one of the products + 4 weeks wash-out period + 6 weeks consuming the other product). - Group 1 (n=15): 6 weeks daily consumption of one probiotic capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one placebo capsule. - Group 2 (n=15): 6 weeks daily consumption of one placebo capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one probiotic capsule.

NCT ID: NCT02928484 Recruiting - Dyspepsia Clinical Trials

Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

Start date: June 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to evaluate whether a probiotic supplement improves gastrointestinal (GI) function.

NCT ID: NCT01464814 Recruiting - Clinical trials for Signs and Symptoms, Digestive

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules

Probiomega
Start date: October 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of the probiotic KE-99 Lactobacillus casei when administered with omega-3 fish oil on probiotic viability, fecal make-up and gastrointestinal (GI) health in healthy adults.